Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Trans-Atlantic partnership seeks answers for cyanotic heart disease
New genetic insights and pipelines for discovery
Confronting one of the world’s greatest health challenges
Collaborative Ted Rogers Centre has taken new aim at heart failure
The new heart risk factor we must all begin to consider
How clonal hematopoiesis may drive heart disease
We’ve now found what immune cells live in the heart
Resident macrophages already well present in healthy hearts
Engineering safe stem cells that can reverse heart damage
Engineering safe stem cells that can reverse heart damage
A new platform to grow and test heart cells
Radisic lab unveils the Biowire II
Alberta researchers discover hidden culprit in heart failure
By suppressing the protein gelsolin, heart function is preserved.
Why cardiologists must focus on their patients with diabetes
Video: Dr. David Fitchett explores a key subject
Extracellular vesicles: what can they tell us about diabetes and heart failure?
Education Fund helps support novel research
Ted Rogers Centre launches four years ago today
Marking the largest gift in Canadian health-care history